Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Alethia BioTherapeutics Series B round

Alethia BioTherapeutics raised a Series B round for 4,700,000 USD in November, 2012.

OverviewStructured DataIssuesContributorsActivity

Currently, there are no issues on this topic.

Find more entities like Alethia BioTherapeutics Series B round

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo